Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Falk Steffen

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Multiple Sclerosis and Related Disorders|May 3, 2022
Brain-derived neurotrophic factor and neurofilament light chain in cerebrospinal fluid are inversely correlated with cognition in Multiple Sclerosis at the time of diagnosisYavor Yalachkov, Victoria Anschütz, Jasmin Jakob, et al.
International Journal of Molecular Sciences|January 25, 2025
Exploring the Link Between Renal Function Fluctuations Within the Physiological Range and Serum/CSF Levels of NfL, GFAP, tTAU, and UCHL1Kimberly Koerbel, Yavor Yalachkov, Tabea Rotter, et al.
Scientific Reports|March 4, 2024
Cognitive decline in post-COVID-19 syndrome does not correspond with persisting neuronal or astrocytic damageFabian Boesl, Yasemin Goereci, Finja Schweitzer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 25, 2026
CSF Proteins Associated With Neuroaxonal Damage in Early Active Multiple SclerosisFelix Luessi, Chiara Starvaggi Cucuzza, Sinah Engel, et al.
Multiple Sclerosis and Related Disorders|February 22, 2023
Serum and cerebrospinal fluid BDNF concentrations are associated with neurological and cognitive improvement in multiple sclerosis: A pilot studyYavor Yalachkov, Victoria Anschütz, Michelle Maiworm, et al.
Brain : a Journal of Neurology|August 25, 2025
Role of CD5 signalling for pro-inflammatory Th17 response in multiple sclerosisKatrin Pape, Nicholas Hanuscheck, Samantha Schmaul, et al.
Journal of Neurology|March 27, 2024
Matching proposed clinical and MRI criteria of aggressive multiple sclerosis to serum and cerebrospinal fluid markers of neuroaxonal and glial injuryMartin A Schaller-Paule, Michelle Maiworm, Jan Hendrik Schäfer, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapiesLars Masanneck, Leoni Rolfes, Liesa Regner-Nelke, et al.
Journal of Neuroinflammation|September 7, 2022
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapsesSteffen Pfeuffer, Leoni Rolfes, Timo Wirth, et al.
Vaccines|July 27, 2024
Clinical and Diagnostic Features of Post-Acute COVID-19 Vaccination Syndrome (PACVS)Anna Katharina Mundorf, Amelie Semmler, Harald Heidecke, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Multiple Sclerosis and Related Disorders|May 3, 2022
Brain-derived neurotrophic factor and neurofilament light chain in cerebrospinal fluid are inversely correlated with cognition in Multiple Sclerosis at the time of diagnosisYavor Yalachkov, Victoria Anschütz, Jasmin Jakob, et al.
International Journal of Molecular Sciences|January 25, 2025
Exploring the Link Between Renal Function Fluctuations Within the Physiological Range and Serum/CSF Levels of NfL, GFAP, tTAU, and UCHL1Kimberly Koerbel, Yavor Yalachkov, Tabea Rotter, et al.
Scientific Reports|March 4, 2024
Cognitive decline in post-COVID-19 syndrome does not correspond with persisting neuronal or astrocytic damageFabian Boesl, Yasemin Goereci, Finja Schweitzer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 25, 2026
CSF Proteins Associated With Neuroaxonal Damage in Early Active Multiple SclerosisFelix Luessi, Chiara Starvaggi Cucuzza, Sinah Engel, et al.
Multiple Sclerosis and Related Disorders|February 22, 2023
Serum and cerebrospinal fluid BDNF concentrations are associated with neurological and cognitive improvement in multiple sclerosis: A pilot studyYavor Yalachkov, Victoria Anschütz, Michelle Maiworm, et al.
Brain : a Journal of Neurology|August 25, 2025
Role of CD5 signalling for pro-inflammatory Th17 response in multiple sclerosisKatrin Pape, Nicholas Hanuscheck, Samantha Schmaul, et al.
Journal of Neurology|March 27, 2024
Matching proposed clinical and MRI criteria of aggressive multiple sclerosis to serum and cerebrospinal fluid markers of neuroaxonal and glial injuryMartin A Schaller-Paule, Michelle Maiworm, Jan Hendrik Schäfer, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapiesLars Masanneck, Leoni Rolfes, Liesa Regner-Nelke, et al.
Journal of Neuroinflammation|September 7, 2022
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapsesSteffen Pfeuffer, Leoni Rolfes, Timo Wirth, et al.
Vaccines|July 27, 2024
Clinical and Diagnostic Features of Post-Acute COVID-19 Vaccination Syndrome (PACVS)Anna Katharina Mundorf, Amelie Semmler, Harald Heidecke, et al.
Pageof 6